Works matching IS 14642662 AND DT 2005 AND VI 6 AND IP 5

Results: 12

The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
Published in:
2005
By:
- Redgrave BE;
- Stone SF;
- French MAH;
- Krueger R;
- James IR;
- Price P
Publication type:
Journal Article
Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 299, doi. 10.1111/j.1468-1293.2005.00304.x
By:
- van den Berg, J. B.;
- Hak, E.;
- Vervoort, S. C. J. M.;
- Hoepelman, I. M.;
- Boucher, C. A. B.;
- Schuurman, R.;
- Schneider, M. M. E.
Publication type:
Article
The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 307, doi. 10.1111/j.1468-1293.2005.00312.x
By:
- Redgrave, B. E.;
- Stone, S. F.;
- French, M. A. H.;
- Krueger, R.;
- James, I. R.;
- Price, P.
Publication type:
Article
HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 313, doi. 10.1111/j.1468-1293.2005.00313.x
By:
- Lospitao, E.;
- Álvarez, A.;
- Soriano, V.;
- Holguín, A.
Publication type:
Article
Laser scanning as a tool for assessment of HIV-related facial lipoatrophy: evaluation of accuracy and reproducibility.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 321, doi. 10.1111/j.1468-1293.2005.00314.x
By:
- Yang, Y.;
- Paton, N. I.
Publication type:
Article
Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 326, doi. 10.1111/j.1468-1293.2005.00316.x
By:
- Rimland, D.;
- Guest, J. L.;
- Hernández, I.;
- del Rio, C.;
- Le, N. A.;
- Brown, W. V.
Publication type:
Article
The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1250 mg twice-daily regimen in HIV-infected patients.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 334, doi. 10.1111/j.1468-1293.2005.00317.x
By:
- Justesen, U. S.;
- Hansen, I. M.;
- Andersen, Å;
- Klitgaard, N. A.;
- Black, F. T.;
- Gerstoft, J.;
- Mathiesen, L. R.;
- Pedersen, C.
Publication type:
Article
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 341, doi. 10.1111/j.1468-1293.2005.00318.x
By:
- Parsonage, M. J.;
- Wilkins, E. G. L.;
- Snowden, N.;
- Issa, B. G.;
- Savage, M. W.
Publication type:
Article
Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 347, doi. 10.1111/j.1468-1293.2005.00319.x
By:
- Henderson, M.;
- Safa, F.;
- Easterbrook, P.;
- Hotopf, M.
Publication type:
Article
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 353, doi. 10.1111/j.1468-1293.2005.00320.x
By:
- Arranz Caso, J. A.;
- López, J. C.;
- Santos, I.;
- Estrada, V.;
- Castilla, V.;
- Sanz, J.;
- Molina, J. P.;
- Fernández Guerrero, M.;
- Górgolas, M.
Publication type:
Article
Clinical benefit of interventions driven by therapeutic drug monitoring.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 360, doi. 10.1111/j.1468-1293.2005.00321.x
By:
- Rendón, A. L.;
- Núñez, M.;
- Jiménez-Nácher, I.;
- González de Requena, D.;
- González-Lahoz, J.;
- Soriano, V.
Publication type:
Article
Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 366, doi. 10.1111/j.1468-1293.2005.00322.x
By:
- Fairley, C. K.;
- Permana, A.;
- Read, T. R. H.
Publication type:
Article